Correction: Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort. (2021)
Attributed to:
Interrogating disease clusters, multimorbidity and adverse outcomes in chronic kidney disease
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1371/journal.pone.0251613
PubMed Identifier: 33956868
Publication URI: http://europepmc.org/abstract/MED/33956868
Type: Journal Article/Review
Volume: 16
Parent Publication: PloS one
Issue: 5
ISSN: 1932-6203